Basic and Clinical Aspects of Malignant Melanoma / Edition 1

by Larry Nathanson

Overview

Where do you begin to look for a recent, authoritative article on the diagnosis or management of particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in-depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdividions such as lung cancer, genitouri­ nary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.

Product Details

ISBN-13:	9780898388565
Publisher:	Springer US
Publication date:	07/31/1987
Series:	Cancer Treatment and Research , #35
Edition description:	1987
Pages:	222
Product dimensions:	6.10(w) x 9.25(h) x 0.02(d)

Table of Contents

I. Basic Biology.- 1. The role of oncogenes in the pathogenesis of malignant melanoma.- 2. Laminin and fibronectin modulate the metastatic activity of melanoma cells.- 3. Structure, function, and biosynthesis of ganglioside antigens associated with human tumors derived from the neuroectoderm.- II. Natural History.- 4. Epidemiology of ocular melanoma.- 5. Malignant melanoma: Prognostic factors.- 6. Endocrine influences on the natural history of human malignant melanoma.- 7. Psychosocial factors associated with prognostic indicators, progression, psychophysiology, and tumor-host response in cutaneous malignant melanoma.- 8. Central nervous system metastases in malignant melanoma.- III. Therapy.- 9. Interferon trials in the management of malignant melanoma and other neoplasms: An overview.- 10. The treatment of malignant melanoma by fast neutrons.